Video player

Right click and save as to download

SAN JUAN CAPISTRANO, CA -- (Marketwire) -- 07/28/09 -- BioCentric President Dennis Fisher today announced the following updates for the production and ALGAE harvesting for the company’s onsite closed loop Photobioreactor system. “The 1800 square feet bioreactor is now operating in a totally “Environmentally Green” process as the system is now completely flooded with reclaimed water. The ALGAE from this initial process is expected to be harvested early next week approximately five days ahead of the original estimated schedule, and based on the current flow rate the ALGAE is expected to be harvested twice daily. The current strain being produced is a   Scenedesmus dimorphus ALGAE culture type when harvested is typically used for producing clean burning Jet Fuel and Gasoline.

Mr. Fisher further stated, “  BioCentric has had the remarkable opportunity to be a pilot developer in this huge upcoming industry, and since Exxon’s announcement last week of the company’s allocated  $600M ALGAE Research & Development program, we are more confident than ever our closed loop system  technology will be in demand worldwide. As a result of the increased number of inquiries regarding ALGAE production and our closed loop system we are today starting assembly of the second closed loop system at our San Juan Capistrano, California Corporate facility and most of the materials are now onsite to commence production. This system will be producing a Spirulina ALGAE strain which when harvested is primarily developed for use in Nutritional supplements.

Company COO Dennis Shen returns this week from Asia where he was able to negotiate several milestones relating to significant cost savings in the manufacturing of  patent pending components for the closed loop photobioreactor system enabling the company to be one of the first manufacturers of commercial size closed loop photobioreactor systems in such a cost effective manner the NAA (National ALAGE Association) President Barry Cohen described BioCentrics all Green cost effective production system as the Wal-Mart of ALGAE production equipment.

Mr. Shen's trip enabled the company to enter negotiations for a Teaming Agreement with Zhenxing Co, Ltd, a Chinese corporation with offices at Lanhe Town, Panyu District, Guangzhou, China. The purpose of the teaming arrangement is where the parties will jointly develop the Algae Biofuel project in China and leverage the resources in China to design and manufacture certain components for Biocentric’s global operations.

Relevant Links & Articles

http://business2press.com/2009/07/14/exxon-mobil-announces-first-real-clean-energy-investment/

www.nationalalgaeassociation.com

www.biocentricenergy.com

www.biocentricenergyalgae.com

About BioCentric Energy Holdings, Inc.

Biocentric Energy Holdings, Inc. is dedicated to the development of new technologies as well as acquiring and fostering companies with innovative technologies designed to provide unique and effective green energy solutions for the 21st century. Along with the cultivation of important relationships and partnerships with synergistic entities, BioCentric Energy has devoted substantial time and effort in research and development in order to bring a range of innovative green alternatives to the marketplace

Safe Harbor Statement:
This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as BEHL or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Dale Baeten, BioCentric Investor Relations: Office: 920-273-7941